Therapeutic combinations and compositions for the treatment of inflammatory bowel disease

Dijkstra, G., Faber, K. N., Harmsen, H. J. M., Steinert, R., Sybesma, W. & Topchyan, A., 13-Aug-2020, Patent No. WO2020161088, 4-Feb-2020, Priority date 4-Feb-2019

Research output: Patent

Copy link to clipboard


The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.
Original languageEnglish
Patent numberWO2020161088
Priority date04/02/2019
Filing date04/02/2020
Publication statusPublished - 13-Aug-2020

ID: 144694867